Literature DB >> 8255371

Analysis of biogenic amines in plasma of hypertensive patients and a control group.

R Andrew1, S A Best, D G Watson, J M Midgley, J L Reid, I B Squire.   

Abstract

Procedures were developed for the determination of 17 circulating amines using gas chromatography-negative ion chemical ionisation mass spectrometry. The amines were quantified against their appropriate deuterated isotopomers. The mean concentrations and ranges of catecholamines and trace amines were high compared with previous studies. In comparison with nonhypertensives, plasma from hypertensives had higher concentrations of the following amines: noradrenaline (t = 4.0%); normetanephrine (t = 6.1%) and metanephrine (t = 1.9%). There were no significant differences between 5HT levels in plasma from hypertensives and controls. The following trace amines could be detected in variable amounts in plasma: p-tyramine, m-tyramine, p-octopamine, m-octopamine, p-synephrine, m-synephrine, and salsolinol. The trace amines melatonin, N-acetyl 5HT, tryptamine, 6-hydroxymelatonin and 5-methoxytryptamine could not be detected in plasma with limits of detection lying in the range 20-100 pg ml-1.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8255371     DOI: 10.1007/bf00978371

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  15 in total

1.  Mass fragmentography of phenylethylamine, m- and p-tyramine and related amines in plasma, cerebrospinal fluid, urine, and brain.

Authors:  F Karoum; H Nasrallah; S Potkin; L Chuang; J Moyer-Schwing; I Phillips; R J Wyatt
Journal:  J Neurochem       Date:  1979-07       Impact factor: 5.372

2.  Simultaneous determination of plasma phenethylamine, phenylethanolamine, tyramine and octopamine by high-performance liquid chromatography using derivatization with fluorescamine.

Authors:  T Yonekura; S Kamata; M Wasa; A Okada; A Yamatodani; T Watanabe; H Wada
Journal:  J Chromatogr       Date:  1988-06-03

3.  Quantitative measurement of octopamines and synephrines in urine using capillary column gas chromatography negative ion chemical ionization mass spectrometry.

Authors:  K E Ibrahim; M W Couch; C M Williams; M B Budd; R A Yost; J M Midgley
Journal:  Anal Chem       Date:  1984-08       Impact factor: 6.986

4.  Red blood cells: in vivo site for transport and inactivation of biogenic amines in man and rats.

Authors:  N Alexander; M Velasquez; N D Vlachakis
Journal:  Life Sci       Date:  1981-08-03       Impact factor: 5.037

5.  Selectively deuterated amino acid analogues. Synthesis, incorporation into proteins and NMR properties.

Authors:  H R Matthews; K S Matthews; S J Opella
Journal:  Biochim Biophys Acta       Date:  1977-03-29

Review 6.  Biogenic amines and their metabolites in body fluids of normal, psychiatric and neurological subjects.

Authors:  B A Davis
Journal:  J Chromatogr       Date:  1989-04-19

7.  A selective radioenzymatic assay for the determination of octopamine and phenylethanolamine in plasma and cerebrospinal fluid. Preliminary results in human and experimental hepatic encephalopathy.

Authors:  F Rossi-Fanelli; C Cangiano; A R Smith; A Bozzi; J H James; L A Kay; B A Perelle; L Capocaccia; J E Fischer
Journal:  Ital J Biochem       Date:  1978 Nov-Dec

8.  Conjugated normetanephrine in human and rat plasma and erythrocytes.

Authors:  S Yoneda; N Alexander; N D Vlachakis
Journal:  Biochem Pharmacol       Date:  1984-07-01       Impact factor: 5.858

Review 9.  Plasma catecholamines and essential hypertension. An analytical review.

Authors:  D S Goldstein
Journal:  Hypertension       Date:  1983 Jan-Feb       Impact factor: 10.190

10.  Choice of control groups in the appraisal of sympathetic nervous activity in essential hypertension.

Authors:  D H Jones; C A Hamilton; J L Reid
Journal:  Clin Sci (Lond)       Date:  1979-10       Impact factor: 6.124

View more
  2 in total

1.  The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls.

Authors:  R Andrew; D G Watson; S A Best; J M Midgley; H Wenlong; R K Petty
Journal:  Neurochem Res       Date:  1993-11       Impact factor: 3.996

Review 2.  Trace amine-associated receptor 1-Family archetype or iconoclast?

Authors:  David K Grandy
Journal:  Pharmacol Ther       Date:  2007-07-17       Impact factor: 12.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.